A. AYDINER Et Al. , "Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells," Journal of Cancer Research and Clinical Oncology , vol.123, no.2, pp.113-117, 1997
AYDINER, A. Et Al. 1997. Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells. Journal of Cancer Research and Clinical Oncology , vol.123, no.2 , 113-117.
AYDINER, A., Ridvanogullari, M., Anil, D., Topuz, E., Nurten, R., & Disci, R., (1997). Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells. Journal of Cancer Research and Clinical Oncology , vol.123, no.2, 113-117.
AYDINER, Adnan Et Al. "Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells," Journal of Cancer Research and Clinical Oncology , vol.123, no.2, 113-117, 1997
AYDINER, Adnan Et Al. "Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells." Journal of Cancer Research and Clinical Oncology , vol.123, no.2, pp.113-117, 1997
AYDINER, A. Et Al. (1997) . "Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells." Journal of Cancer Research and Clinical Oncology , vol.123, no.2, pp.113-117.
@article{article, author={Adnan AYDINER Et Al. }, title={Combined effects of epirubicin and tamoxifen on the cell-cycle phases in estrogen-receptor-negative Ehrlich ascites tumor cells}, journal={Journal of Cancer Research and Clinical Oncology}, year=1997, pages={113-117} }